First-year drug therapy of new-onset rheumatoid and undifferentiated arthritis: a nationwide register-based study.

Muilu, Paula; Rantalaiho, Vappu; Kautiainen, Hannu; Virta, Lauri J; Eriksson, Johan G; Puolakka, Kari

Muilu, Paula; Rantalaiho, Vappu; Kautiainen, Hannu; Virta, Lauri J; Eriksson, Johan G; Puolakka, Kari.

Afiliación

Muilu P; Department of Medicine, Tampere University Hospital, Teiskontie 35, 33520 Tampere, Finland.
Rantalaiho V; Centre for Rheumatic Diseases, Tampere University Hospital, Tampere, Finland.
Kautiainen H; Centre for Rheumatic Diseases, Tampere University Hospital, Tampere, Finland.
Virta LJ; Faculty on Medicine and Health Technology, Tampere University, Tampere, Finland.
Eriksson JG; Primary Health Care Unit, Kuopio University Hospital, Kuopio, Finland.
Puolakka K; Folkhälsan Research Center, Helsinki, Finland.

BMC Rheumatol ; 4: 34, 2020.

Article en En | MEDLINE | ID: mdl-32637868

Palabras clave

Antirheumatic drugs; Biologic therapy; Disease modifying; Rheumatoid arthritis; Undifferentiated arthritis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: BMC Rheumatol Año: 2020 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google